Close

Protalix BioTherapeutics (PLX) Reports Q4 Loss of $0.29/Share

March 8, 2016 7:35 AM EST

Protalix BioTherapeutics (NYSE: PLX) reported Q4 EPS of ($0.29), versus ($0.36) reported last year. Revenue for the quarter came in at $4.4 million, versus $3.5 million reported last year.

For earnings history and earnings-related data on Protalix BioTherapeutics (PLX) click here.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Earnings

Related Entities

Earnings